Related Experiment Videos

[Role of C-reactive protein in atherogenesis]

Magdalena Boncler1, Bogusława Luzak, Cezary Watala

  • 1Zakład Zaburzeń Krzepniecia Krwi, Uniwersytet Medyczny w Łodzi, Łódz, Poland. mboncler@csk.umed.lodz.pl

Postepy Higieny I Medycyny Doswiadczalnej (Online)
|October 25, 2006
PubMed

Insights

C-reactive protein (CRP) is now recognized as a key factor in atherosclerosis, not just an inflammation marker. Elevated CRP levels predict cardiovascular disease risk in both patients and healthy individuals.

Area of Science:

  • Biochemistry
  • Immunology
  • Cardiology

Context:

  • C-reactive protein (CRP) was traditionally a biomarker for inflammation.
  • High-sensitivity assays have revealed CRP's significant role in cardiovascular disease.
  • CRP levels increase during acute coronary syndromes and predict risk.

Purpose:

  • To explore the role of C-reactive protein in the pathophysiology of atherosclerosis.
  • To investigate the mechanisms of CRP action in circulation.
  • To examine the contribution of CRP gene variations to vascular complications.

Summary:

  • C-reactive protein (CRP) is implicated as a direct contributor to atherosclerosis.
  • CRP acts as a mediator of inflammation and thrombotic complications.
  • Genetic variations in the CRP gene may influence vascular pathophysiology.

Impact:

  • CRP is a powerful independent predictor of cardiovascular disease.
  • Understanding CRP's role enhances cardiovascular risk assessment in diverse populations.
  • Further research into CRP mechanisms and genetics can inform therapeutic strategies.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Inflammation01:38

Inflammation

Overview
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...